Richard W Mott - Net Worth and Insider Trading

Richard W Mott Net Worth

The estimated net worth of Richard W Mott is at least $9 Million dollars as of 2024-11-13. Richard W Mott is the Director of Treace Medical Concepts Inc and owns about 1,072,944 shares of Treace Medical Concepts Inc (TMCI) stock worth over $9 Million. Details can be seen in Richard W Mott's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard W Mott has not made any transactions after 2024-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Richard W Mott

Richard W Mott Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard W Mott owns 3 companies in total, including Endologix Inc (ELGXQ) , Lyra Therapeutics Inc (LYRA) , and Treace Medical Concepts Inc (TMCI) .

Click here to see the complete history of Richard W Mott’s form 4 insider trades.

Insider Ownership Summary of Richard W Mott

Ticker	Comapny	Transaction Date	Type of Owner
ELGXQ	Endologix Inc	2020-06-19	director
LYRA	Lyra Therapeutics Inc	2020-04-30	10 percent owner
TMCI	Treace Medical Concepts Inc	2024-05-24	director

Richard W Mott Latest Holdings Summary

Richard W Mott currently owns a total of 1 stock. Richard W Mott owns 1,072,944 shares of Treace Medical Concepts Inc (TMCI) as of May 24, 2024, with a value of $9 Million.

Latest Holdings of Richard W Mott

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TMCI	Treace Medical Concepts Inc	2024-05-24	1,072,944	8.04	8,626,470

Holding Weightings of Richard W Mott

Richard W Mott Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard W Mott has made a total of 16 transactions in Treace Medical Concepts Inc (TMCI) over the past 5 years, including 3 buys and 13 sells. The most-recent trade in Treace Medical Concepts Inc is the acquisition of 18,000 shares on May 24, 2024, which cost Richard W Mott around $93,420.

Insider Trading History of Richard W Mott

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard W Mott Trading Performance

GuruFocus tracks the stock performance after each of Richard W Mott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard W Mott is 24.91%. GuruFocus also compares Richard W Mott's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard W Mott within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard W Mott's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard W Mott

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	18.7
Relative Return to S&P 500(%)	15.45

Richard W Mott Ownership Network

Ownership Network List of Richard W Mott

No Data

Ownership Network Relation of Richard W Mott

Richard W Mott Owned Company Details

What does Endologix Inc do?

Who are the key executives at Endologix Inc?

Richard W Mott is the director of Endologix Inc. Other key executives at Endologix Inc include director & CEO and Director John Onopchenko , Chief Medical Officer Matthew Thompson , and Controller and Corp Secretary Timothy Nicholas Brady .

Endologix Inc (ELGXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Endologix Inc (ELGXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endologix Inc (ELGXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Endologix Inc (ELGXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Endologix Inc Insider Transactions

No Available Data

What does Lyra Therapeutics Inc do?

Who are the key executives at Lyra Therapeutics Inc?

Richard W Mott is the 10 percent owner of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Nbvm Gp, Llc , and director & 10 percent owner Edward T Anderson .

Lyra Therapeutics Inc (LYRA) Insider Trades Summary

Over the past 18 months, Richard W Mott made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Nbvm Gp, Llc , and a net purchase of 1,805,416 shares made by Edward T Anderson .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lyra Therapeutics Inc Insider Transactions

No Available Data

What does Treace Medical Concepts Inc do?

Who are the key executives at Treace Medical Concepts Inc?

Richard W Mott is the director of Treace Medical Concepts Inc. Other key executives at Treace Medical Concepts Inc include director & 10 percent owner & Chief Executive Officer John T. Treace , See Remarks Sean F. Scanlan , and Chief HR Officer Daniel E. Owens .

Treace Medical Concepts Inc (TMCI) Insider Trades Summary

Over the past 18 months, Richard W Mott made 3 insider transaction in Treace Medical Concepts Inc (TMCI) with a net purchase of 150,100. Other recent insider transactions involving Treace Medical Concepts Inc (TMCI) include a net purchase of 730,000 shares made by John T. Treace , a net purchase of 412,000 shares made by James T Treace , and a net sale of 1,090,821 shares made by F Barry Bays .

In summary, during the past 3 months, insiders sold 0 shares of Treace Medical Concepts Inc (TMCI) in total and bought 219,000 shares, with a net purchase of 219,000 shares. During the past 18 months, 1,115,821 shares of Treace Medical Concepts Inc (TMCI) were sold and 1,466,456 shares were bought by its insiders, resulting in a net purchase of 350,635 shares.

Treace Medical Concepts Inc (TMCI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Treace Medical Concepts Inc Insider Transactions

No Available Data

Richard W Mott Mailing Address

Above is the net worth, insider trading, and ownership report for Richard W Mott. You might contact Richard W Mott via mailing address: 1221 Crossman Avenue, Sunnyvale Ca 94089.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.